The North America cardiovascular and soft tissue repair patches market is projected to grow to USD 2.81 billion in 2026. The increase in cardiovascular disease, congenital heart disease, hernia, and musculoskeletal injury, as well as utilization of biologic and synthetic patches in cardiac operations, vascular reconstruction, hernia repair, and tendon and ligament repair, have been cited as reasons for growth. These trends have been analysed by Deepa Pandey, Senior Research Analyst. The outcomes of the research will be useful to medical device manufacturers, biomaterial suppliers, hospitals and ambulatory surgical centers
